1AD
Click for more information
0.00% 2.2¢ adalta limited

Ann: Positive AD-214 Phase I extension study results, page-189

  1. asx11
    3,618 Posts.
    lightbulb Created with Sketch. 389
    clock Created with Sketch.
    27/03/24
    10:39
    Post #: 73078395
    They wouldn't get the company for that because we wouldn't allow it. The company also has 2 paths to funding, they may not even end up partnering with pharma.
    Last edited by asx11: 27/03/24
    1AD Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.10M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $0 3

Buyers (Bids)

No. Vol. Price($)
1 20000 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 82501 1
View Market Depth
Last trade - 10.51am 09/08/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.